Cardiac Power Output in Cardiogenic Shock Patients

The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.

Inclusion Criteria:LVEF ≤ 35%Referred for RHC for:Evaluation for advanced heart failure therapies, including LVAD, OHT, temporary or long-term inotrope therapy, or counter-pulsation (temporary or long-term with NuPulse device ORAccurate assessment of invasive hemodynamics due to worsening clinical status, ORAssessment of myocardial recovery for consideration of LVAD or counter-pulsation (temporary IABP or long-term with NuPulse device) decommissioning or removal ORAssessment of cardiac function and valvular abnormalities prior to planned valvular surgery for MR or AIEstimated glomerular filtration rate (eGFR) ≥ 30 ml/min/1.73 m2Age ≥ 18 years-oldIntent for admission based on RHC dataExclusion Criteria:eGFR < 30 ml/min/1.73 m2Severe, non-revascularized coronary artery diseaseConcurrent acute coronary syndromeAge < 18 years-oldHistory of significant ventricular arrhythmia without an ICD